Importance of Highly Potent Molecules in Modern-Day Drugs

Highly potent molecules, often referred to as highly potent active pharmaceutical ingredients (HPAPIs), play a crucial role in modern drug development and therapy.

The development of HPAPIs drives innovation in the pharmaceutical industry, leading to the creation of new and more effective drugs. HPAPIs are highly effective at much smaller dosages compared to non-potent APIs. This means they can achieve the desired therapeutic effect with lower doses, reducing the risk of side effects.

These molecules are highly specific in their action, allowing them to target diseased cells more precisely. This is particularly beneficial in treatments for conditions like cancer, where precision is crucial. By targeting specific pathways and cells, HPAPIs can improve patient outcomes, offering more effective treatments with fewer side effects.

Register for this webinar today to delve into the cutting-edge world of highly potent active pharmaceutical ingredients and their transformative role in modern medicine.

Speaker

Sankappa Rai, PhD, PMP®, Sr. Director, Technical Operations, Chemical Development and Manufacturing Solutions, Aragen

Sankappa Rai is a seasoned pharmaceutical professional with over two decades of experience in small molecule discovery, process development, CMC, HPAPI, ADCs and contract manufacturing (CDMO/CMO). Currently serving as Senior Director, CMC – Technical Operations at Aragen Life Sciences, leading end-to-end CMC development and late-phase programs for NCEs, APIs and intermediates

At Aragen, he is responsible for process development, validation and commercial supply, along with P&L ownership for Chemical Development Solutions. He plays a strategic role in customer engagement and long-term collaboration building.

Message Presenter